Literature DB >> 16594638

Shear-induced variability in the United States Pharmacopeia Apparatus 2: modifications to the existing system.

Jennifer L Baxter1, Joseph Kukura, Fernando J Muzzio.   

Abstract

The hydrodynamics within the United States Pharmacopeia Apparatus 2 have been shown to be highly non-uniform with a potential to yield substantial variability in dissolution rate measurements. Through the use of readily available engineering tools, several geometric modifications to the device were evaluated in this study. Specifically, we examined the influence of impeller clearance, agitator type (radial and axial), and vessel geometry (PEAK vessel) on the fluid flow properties and their relation to measured dissolution rates. Increasing the impeller clearance was observed to exacerbate the heterogeneity in shear and would likely result in greater variability in dissolution measurements. Altering the impeller type was shown to yield changes in the hydrodynamic behavior; however, the overall properties and problems with the test remain the same. Use of the PEAK vessel was observed to reduce shear heterogeneity in the regions where tablets are most likely to visit during testing; however, higher shear rates may result in the inability to discriminate between true differences in dissolution rates.

Mesh:

Substances:

Year:  2006        PMID: 16594638      PMCID: PMC2750955          DOI: 10.1208/aapsj070483

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  5 in total

1.  Cause of high variability in drug dissolution testing and its impact on setting tolerances.

Authors:  S A Qureshi; J Shabnam
Journal:  Eur J Pharm Sci       Date:  2001-01       Impact factor: 4.384

2.  Loss of sensitivity in distinguishing renal differences in dissolution rates due to increasing intensity of agitation.

Authors:  W E HAMLIN; E NELSON; B E BALLARD; J G WAGNER
Journal:  J Pharm Sci       Date:  1962-05       Impact factor: 3.534

3.  Shear distribution and variability in the USP Apparatus 2 under turbulent conditions.

Authors:  J Kukura; J L Baxter; F J Muzzio
Journal:  Int J Pharm       Date:  2004-07-26       Impact factor: 5.875

4.  Typical variability in drug dissolution testing: study with USP and FDA calibrator tablets and a marketed drug (glibenclamide) product.

Authors:  S A Qureshi; I J McGilveray
Journal:  Eur J Pharm Sci       Date:  1999-02       Impact factor: 4.384

5.  Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.

Authors:  D C Cox; W B Furman
Journal:  J Pharm Sci       Date:  1982-04       Impact factor: 3.534

  5 in total
  6 in total

1.  What is a suitable dissolution method for drug nanoparticles?

Authors:  Desmond Heng; David J Cutler; Hak-Kim Chan; Jimmy Yun; Judy A Raper
Journal:  Pharm Res       Date:  2008-03-05       Impact factor: 4.200

Review 2.  The science of USP 1 and 2 dissolution: present challenges and future relevance.

Authors:  Vivian Gray; Gregg Kelly; Min Xia; Chris Butler; Saji Thomas; Stephen Mayock
Journal:  Pharm Res       Date:  2009-01-23       Impact factor: 4.200

3.  Particle Image Velocimetry Evaluation of Fluid Flow Profiles in USP 4 Flow-Through Dissolution Cells.

Authors:  Hiroyuki Yoshida; Akemi Kuwana; Hiroko Shibata; Ken-Ichi Izutsu; Yukihiro Goda
Journal:  Pharm Res       Date:  2015-03-20       Impact factor: 4.200

Review 4.  Physiological parameters for oral delivery and in vitro testing.

Authors:  Deanna M Mudie; Gordon L Amidon; Gregory E Amidon
Journal:  Mol Pharm       Date:  2010-09-07       Impact factor: 4.939

Review 5.  Formulation predictive dissolution (fPD) testing to advance oral drug product development: An introduction to the US FDA funded '21st Century BA/BE' project.

Authors:  Bart Hens; Patrick D Sinko; Nicholas Job; Meagan Dean; Jozef Al-Gousous; Niloufar Salehi; Robert M Ziff; Yasuhiro Tsume; Marival Bermejo; Paulo Paixão; James G Brasseur; Alex Yu; Arjang Talattof; Gail Benninghoff; Peter Langguth; Hans Lennernäs; William L Hasler; Luca Marciani; Joseph Dickens; Kerby Shedden; Duxin Sun; Gregory E Amidon; Gordon L Amidon
Journal:  Int J Pharm       Date:  2018-06-23       Impact factor: 5.875

6.  Measuring dissolution profiles of single controlled-release drug pellets.

Authors:  Heran C Bhakta; Jessica M Lin; William H Grover
Journal:  Sci Rep       Date:  2020-11-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.